Comparison of three sedative agents; intranasal dexmedetomidine, intranasal midazolam and inhalation nitrous oxide for children undergoing dental treatment
Phase 3
Completed
- Conditions
- Health Condition 1: K029- Dental caries, unspecified
- Registration Number
- CTRI/2022/03/041180
- Lead Sponsor
- Janiani Palak Ramesh
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 14
Inclusion Criteria
1.ASA I Category
2.Behavior category: Frankl Scale 2 negative
3.Requiring pulpectomy in at least three posterior teeth in the lower arch
4.No cognitive impairment
Exclusion Criteria
1.Patients who recently used medications like erythromycin or anticonvulsants that may interfere with the pharmacokinetics of midazolam.
2.Children with any condition that predisposes them to airway obstruction or difficulties (eg adenoid hyperplasia, nasal septum problems, enlarged turbinates or nasal polyp).
3.Frankl scale #1 (definitely negative)
4.Children with upper or lower respiratory tract infections
5. Children with special health care needs
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method